Bank of New York Mellon Corp - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 172 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$13,594,414
-1.6%
409,347
-6.6%
0.00%0.0%
Q3 2022$13,821,000
+2.6%
438,342
-1.0%
0.00%0.0%
Q2 2022$13,465,000
+15.4%
442,682
-1.5%
0.00%
+50.0%
Q1 2022$11,665,000
+27.2%
449,354
-0.0%
0.00%0.0%
Q4 2021$9,171,000
+2.8%
449,555
-3.0%
0.00%0.0%
Q3 2021$8,921,000
-15.3%
463,688
-2.3%
0.00%0.0%
Q2 2021$10,528,000
-19.9%
474,633
-5.2%
0.00%
-33.3%
Q1 2021$13,148,000
+38.2%
500,906
-1.6%
0.00%
+50.0%
Q4 2020$9,512,000
+8.6%
508,924
-1.3%
0.00%0.0%
Q3 2020$8,756,000
-28.3%
515,683
-1.6%
0.00%
-33.3%
Q2 2020$12,207,000
+170.4%
524,117
-2.5%
0.00%
+200.0%
Q1 2020$4,515,000
-16.7%
537,630
-3.1%
0.00%0.0%
Q4 2019$5,423,000
+10.6%
554,937
+7.4%
0.00%0.0%
Q3 2019$4,903,000
-24.1%
516,649
-4.9%
0.00%
-50.0%
Q2 2019$6,456,000
-47.8%
543,357
-22.6%
0.00%
-33.3%
Q1 2019$12,367,000
+2.6%
702,272
+1.1%
0.00%
-25.0%
Q4 2018$12,054,000
-1.5%
694,380
-15.5%
0.00%
+33.3%
Q3 2018$12,239,000
-5.2%
821,462
+1.2%
0.00%
-25.0%
Q2 2018$12,908,000
+13.9%
811,847
+1.7%
0.00%
+33.3%
Q1 2018$11,330,000
+2.0%
797,910
+0.5%
0.00%0.0%
Q4 2017$11,113,000
-10.8%
793,855
-8.9%
0.00%0.0%
Q3 2017$12,463,000
-8.3%
871,560
+1.0%
0.00%
-25.0%
Q2 2017$13,595,000
+15.4%
863,183
+1.1%
0.00%
+33.3%
Q1 2017$11,778,000
-41.7%
853,470
-25.2%
0.00%
-50.0%
Q4 2016$20,198,000
-6.1%
1,141,246
+2.3%
0.01%0.0%
Q3 2016$21,510,000
-20.7%
1,115,121
-19.9%
0.01%
-25.0%
Q2 2016$27,140,000
-8.2%
1,391,768
-2.9%
0.01%
-11.1%
Q1 2016$29,557,000
+2.4%
1,434,041
+2.0%
0.01%0.0%
Q4 2015$28,862,000
+10.1%
1,406,517
-8.3%
0.01%
+12.5%
Q3 2015$26,218,000
-5.0%
1,533,207
+3.6%
0.01%0.0%
Q2 2015$27,600,000
+0.1%
1,480,625
+2.5%
0.01%
+14.3%
Q1 2015$27,569,000
+159.8%
1,444,878
+124.1%
0.01%
+133.3%
Q4 2014$10,612,000
-71.9%
644,692
-69.7%
0.00%
-70.0%
Q3 2014$37,701,000
-57.0%
2,131,171
-49.9%
0.01%
-16.7%
Q2 2014$87,752,000
+105.9%
4,251,548
+117.4%
0.01%0.0%
Q1 2014$42,623,000
-19.7%
1,956,069
-2.3%
0.01%
-20.0%
Q4 2013$53,109,000
-43.9%
2,001,864
-50.1%
0.02%
+7.1%
Q3 2013$94,746,000
+113.1%
4,009,412
+93.9%
0.01%0.0%
Q2 2013$44,468,0002,068,2370.01%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q2 2019
NameSharesValueWeighting ↓
Acuitas Investments, LLC 283,983$6,299,0003.15%
Euclidean Technologies Management, LLC 128,088$2,841,0002.26%
GLOBEFLEX CAPITAL L P 185,939$4,124,0000.74%
HUSSMAN STRATEGIC ADVISORS, INC. 144,000$3,194,0000.66%
CLARK ESTATES INC/NY 220,000$4,880,0000.64%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,424,274$31,590,0000.56%
SYSTEMATIC FINANCIAL MANAGEMENT LP 789,827$17,518,0000.53%
EARNEST PARTNERS LLC 3,885,748$86,186,0000.51%
MOODY ALDRICH PARTNERS LLC 137,075$3,040,0000.43%
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. 414,323$9,190,0000.33%
View complete list of MERIDIAN BIOSCIENCE INC shareholders